臺北醫學大學生醫器材研究中心

Pharmacology, Toxicology and Pharmaceutical Science

1. Acute Heart Infarction 12%
2. Adverse Event 17%
3. Alginic Acid 15%
4. Alkaline Phosphatase 10%
5. All Cause Mortality 9%
6. Angiotensin II 17%
7. Antihypertensive Agent 9%
8. Antiinfective Agent 18%
9. Antioxidant 25%
10. Asthma 15%
11. Atrial Fibrillation 11%
12. Biocompatibility 14%
13. Biological Marker 11%
14. Bipolar Disorder 16%
15. Breast Cancer 21%
16. Calcium Phosphate 14%
17. Cardiovascular Disease 17%
18. Case-Control Study 11%
19. Cell Viability 21%
20. Chemotherapy 16%
21. Chitosan 55%
22. Chronic Kidney Failure 43%
23. Chronic Obstructive Lung Disease 37%
24. Cisplatin 9%
25. Clinical Trial 10%
26. Cohort Study 50%
27. Colon Cancer 9%
28. Combination Therapy 23%
29. Cyclooxygenase 2 9%
30. Cytokine 14%
31. Cytotoxicity 24%
32. Diabetes Mellitus 18%
33. Disease 52%
34. Doxorubicin 24%
35. Drug Delivery System 15%
36. Drug Release 10%
37. Dry Eye 10%
38. End Stage Renal Disease 12%
39. Endothelin 1 25%
40. Epidermal Growth Factor Receptor 26%
41. Epigallocatechin Gallate 12%
42. Fibrinogen 11%
43. Fibrosis 11%
44. Fucoidan 29%
45. Gelatin 31%
46. Growth Factor 15%
47. Heart Infarction 12%
48. Hemodialysis 29%
49. Hyaluronic Acid 29%
50. Hydroxyapatite 12%
51. Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor 12%
52. Implant 11%
53. Infection 20%
54. Infectious Agent 11%
55. Inflammation 39%
56. Injury 16%
57. Kidney Disease 10%
58. Leporidae 12%
59. Lipopolysaccharide 16%
60. Liposome 19%
61. Liver Cell Carcinoma 11%
62. Lung Adenocarcinoma 11%
63. Lung Cancer 30%
64. Malignant Neoplasm 100%
65. Mesoporous Silica Nanoparticle 11%
66. Mitogen Activated Protein Kinase 17%
67. Mouse 47%
68. Mouse Model 10%
69. Nanocarrier 13%
70. Nanomaterial 11%
71. Nanoparticle 79%
72. Neoplasm 55%
73. Nitric Oxide 15%
74. Non Insulin Dependent Diabetes Mellitus 9%
75. Non Small Cell Lung Cancer 11%
76. Nuclear Factor 10%
77. Parkinson's Disease 11%
78. Placebo 10%
79. Polyglutamic Acid 10%
80. Polysaccharide 12%
81. Prevalence 12%
82. Randomized Controlled Trial 43%
83. Rat Model 13%
84. Reactive Oxygen Metabolite 40%
85. Receptor 10%
86. Resveratrol 9%
87. Side Effect 9%
88. Sleep Disorder 10%
89. Sleep Disordered Breathing 27%
90. Survival Rate 12%
91. Symptom 17%
92. Therapeutic Effect 14%
93. Thrombosis 10%
94. Tumor Growth 15%
95. Tumor Necrosis Factor 15%
96. Urotensin II 10%
97. Vaccination Policy 26%
98. Western Blot 11%
99. Wound 11%
100. Wound Healing 17%

Medicine and Dentistry

1. Acute Heart Infarction 11%
2. Adverse Event 12%
3. Angiogenesis 10%
4. Apoplexy 35%
5. Asthma 10%
6. Atrial Fibrillation 10%
7. Biological Marker 13%
8. Blood Pressure 16%
9. Bone Defect 10%
10. Bone Graft 12%
11. Bone Regeneration 14%
12. Bone Substitutes 10%
13. Breast Cancer 15%
14. Calcium Sulfate 10%
15. Cancer Cell 19%
16. Cardiovascular Disease 12%
17. Cardiovascular System 11%
18. Case-Control Study 10%
19. Cell Proliferation 12%
20. Cell Therapy 16%
21. Chondrocyte 18%
22. Chronic Kidney Disease 35%
23. Chronic Obstructive Pulmonary Disease 29%
24. Clinical Trial 11%
25. Cohort Analysis 44%
26. Combination Therapy 11%
27. Computer Assisted Tomography 14%
28. COVID-19 16%
29. Dental Implant 14%
30. Dental Pulp Stem Cell 10%
31. Diabetes 12%
32. Diabetes Mellitus 22%
33. Diagnosis 12%
34. Disease 28%
35. Drug Therapy 13%
36. Edentulism 10%
37. Electrostimulation 12%
38. Endothelial Cell 16%
39. Epidermal Growth Factor Receptor 14%
40. Fibroblast 22%
41. Functional Electrical Stimulation 13%
42. Gelatin 15%
43. Gene Expression 12%
44. Growth Factor 17%
45. Hazard Ratio 24%
46. Health Care Cost 15%
47. Heart Failure 10%
48. Heart Rate Variability 10%
49. Hemodialysis 17%
50. Hydroxylapatite 13%
51. Implant 47%
52. In Vitro 64%
53. Infection 15%
54. Influenza Vaccination 22%
55. Injury 19%
56. Isotopes of Calcium 30%
57. Knee 14%
58. Knee Osteoarthritis 10%
59. Lung Cancer 19%
60. Magnetic Resonance Imaging 10%
61. Malignant Neoplasm 39%
62. Medicine 33%
63. Mesenchymal Stem Cell 15%
64. Meta-Analysis 55%
65. Metastatic Carcinoma 12%
66. Nanoparticle 14%
67. Neoplasm 22%
68. Nephropathy 11%
69. Obstructive Sleep Apnea 20%
70. Odds Ratio 17%
71. Oral Implants 21%
72. Osseointegration 19%
73. Ossification 13%
74. Osteoarthritis 11%
75. Osteoblast 12%
76. Osteolysis 15%
77. Parkinson's Disease 11%
78. Particular Matter 2.5 10%
79. Platelet 47%
80. Platelet Lysate 34%
81. Platelet-Rich Fibrin 13%
82. Prevalence 13%
83. Programmed Cell Death 14%
84. Pulse Rate 11%
85. Quality of Life 12%
86. Randomized Controlled Trial 47%
87. Rehabilitation Engineering 17%
88. Restylane 29%
89. Signal Transduction 11%
90. Spinal Cord Injury 14%
91. Surgery 16%
92. Symptom 22%
93. Systematic Review 36%
94. Thrombocyte Concentrate 16%
95. Traumatic Brain Injury 12%
96. Tumor Necrosis Factor 10%
97. Tumor Progression 11%
98. Upper Limb 11%
99. Urination 12%
100. Vascular Endothelial Cell 10%